此页面是自动翻译的，不保证翻译的准确性。请参阅英文版对于源文本。

Fertility Preservation in Men Affected by Cancer

2020年3月24日更新者：University Hospital, Basel, Switzerland

Fertility Preservation in Men Affected by Cancer: Assessment of Patients' Needs and Development of an Online Decision-aid

This is a single center cross-sectional retrospective study with a quantitative and qualitative approach (phase 1 and 2). In phase 1 an online survey will be realized and targets male cancer survivors. Phase 2 will take a qualitative approach, in which information about patient's experiences, needs and helpful support will be collected by establishing focus groups of cancer patients who had been diagnosed during the reproductive age.

In the end, the results of this study will be integrated into the development of an online support tool concerning Fertility Preservation (FP).

研究概览

地位

完全的

条件

癌症

干预/治疗

研究类型

观察性的

注册 (实际的)

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

瑞士
- - Basel、瑞士、4031
    - Frauenklinik University Hospital Basel

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

男性

取样方法

概率样本

研究人群

Cancer patients who are/were possible candidates for FP (patients with fertility compromising cancer treatment) will be invited to participate. Eligible patients will be approached by their former or current treating oncologist, urologist or specialist in reproductive medicine.

描述

Inclusion Criteria:

German speaking
Cancer diagnosis within the last 10 years (minimum age at diagnosis 13 years)
Cancer therapy that was expected to impair fertility

Exclusion Criteria:

Prepubertal at diagnosis

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

研究衡量的是什么？

主要结果指标

结果测量	措施说明	大体时间
male cancer patients level of information with regard to FP 大体时间：Phase 1 online survey at baseline	Phase 1: exploratory online survey inquiring male cancer patients level of information with regard to FP	Phase 1 online survey at baseline
male cancer patients level of information with regard to FP 大体时间：Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)	Phase 2: interview (strictly exploratory) in focus groups collecting data on male cancer patients level of information with regard to FP	Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)

次要结果测量

结果测量	措施说明	大体时间
male cancer patients needs regarding decision-making about FP 大体时间：Phase 1 online survey at baseline	exploratory online survey inquiring which kind of support regarding decision-making about FP do male cancer patients consider helpful	Phase 1 online survey at baseline
male cancer patients expectation with regard to an online DA tool about FP 大体时间：Phase 1 online survey at baseline	exploratory online survey inquiring how an online Decision Aid (DA) tool about FP has to be designed in order to be helpful for male cancer patients	Phase 1 online survey at baseline
male cancer patients needs regarding decision-making about FP 大体时间：Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)	Phase 2: interview (strictly exploratory) in focus groups evaluating which kind of support regarding decision-making about FP male cancer patients consider helpful	Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)
male cancer patients expectation with regard to an online DA tool about FP 大体时间：Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)	Phase 2: interview (strictly exploratory) in focus groups evaluating how an online DA tool about FP has to be designed in order to be helpful for male cancer patients	Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

University Hospital, Basel, Switzerland

合作者

Krebsforschung Schweiz, Bern, Switzerland

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年1月2日

初级完成 (实际的)

2020年2月13日

研究完成 (实际的)

2020年2月13日

研究注册日期

首次提交

2019年2月26日

首先提交符合 QC 标准的

2019年3月12日

首次发布 (实际的)

2019年3月15日

研究记录更新

最后更新发布 (实际的)

2020年3月25日

上次提交的符合 QC 标准的更新

2020年3月24日

最后验证

2020年3月1日

Fertility Preservation in Men Affected by Cancer